Podcasts about cgms

Your annual labs can reveal far more than most people realize—if you know how to interpret them. In this episode of A Whole New Level, Dr. Rich Joseph walks through how to read basic blood work like the CBC, electrolytes, and urinalysis, and how to use those numbers as feedback loops, not pass/fail judgments.He explains which values matter most, what trends reveal over time, and how to connect lab data to sleep, training, nutrition, and stress.What the Complete Blood Count (CBC) actually measuresHow to identify early signs of iron or B-vitamin deficiencyWhat white blood cell patterns reveal about immunity and stressHow electrolytes reflect cellular energy, hydration, and training loadWhy urinalysis is underrated (and how to read it quickly)How to use lab trends—not single snapshots—to guide health decisionsSign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl

Kristine Batty, PHD, APRN, BC-ADM, CDCES, FADCES joins this episode of Danatech Talks–a special series from The Huddle– to provide a high-level overview on continuous glucose monitors (CGMs). Kristine touches on the basics of how CGMs work, what CGM devices are out there today, what the different devices measure, and how CGM technology impacts clinical decision making. This episode was supported by educational grant funding from Abbott.Explore the latest in diabetes technology as well as trainings and resources on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsListen to the first episode of our Danatech Talks diabetes technology series: https://thehuddle.simplecast.com/episodes/basics-diabetes-technology-for-health-care-professionals Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of The Spoon Podcast, registered dietitian and longtime CNN food journalist Carolyn O'Neil joins Mike to traverse the fiberverse and discuss the growing trend of fibermaxxing. Carolyn discusses the science behind different types of fiber, and why Gen Z's favorite prebiotic sodas are suddenly everywhere. She also breaks down how fiber actually works in the body, why most people get only half the recommended amount, and how social media, CPG innovation, and even CGMs are reshaping consumer nutrition habits. If you haven't subscribed to Carolyn's podcast, you can find it on Apple Podcasts or Spotify. Learn more about your ad choices. Visit megaphone.fm/adchoices

Most people assume their blood sugar is “fine” because their fasting glucose was normal at their annual physical.But here's the truth…

This episode covers: • Cocoa Extract Cuts Heart Deaths A massive COSMOS trial found that older adults taking high flavanol cocoa extract daily saw a 27 percent reduction in cardiovascular deaths along with drops in inflammation markers like HSCRP. Women showed unique anti inflammatory cytokine shifts, pointing to a broader longevity effect. Dave explains why cocoa extract is becoming a foundational nutrient for vascular health rather than a dessert ingredient. Source: https://www.sciencedaily.com/releases/2025/09/250926135957.htm • AI Stethoscope for Home Diagnostics Lapsi Health's Keikku 2.0 just became the first FDA cleared AI powered digital stethoscope for both clinicians and home users. It records heart and lung sounds, analyzes them instantly, and flags early warning signs before symptoms appear. Dave breaks down why tools like this move you from reactive to predictive medicine and why they belong in every quantified self toolkit. Source: https://www.prnewswire.com/news-releases/lapsi-health-unveils-keikku-2-0-worlds-first-fda-cleared-digital-stethoscope-with-integrated-ai-scribe-302585083.html?utm_source=chatgpt.com • Beef Organ Supplements Surge Beef organ supplements have exploded more than 8,000 percent this year, driven largely by women reporting improvements in energy, hormones, mood, and skin. Liver, kidney, and heart deliver vitamin A, heme iron, B12, copper, and choline that modern diets often lack. Dave covers sourcing concerns, purity standards, and why this shift reflects a move from fear based nutrition to evolutionary nutrition. Source: https://www.verywellhealth.com/beef-organ-supplement-11710185?utm_source=chatgpt.com • Spirulina for Collagen and DNA Protection New research highlights spirulina's ability to support collagen production, reduce oxidative stress, protect DNA, and improve glucose and lipid balance. It is becoming a staple of eco focused anti aging routines and is driving the viral green stacking trend with chlorella and chlorophyll. Dave explains why spirulina functions as a clean daily defense against oxidative stress. Source: https://www.news-medical.net/news/20250707/Is-Spirulina-the-Next-Anti-Aging-Superfood.aspx • Health Data Privacy Reform A new Senate bill aims to extend HIPAA level protections to wearables, genomic tools, glucose monitors, and wellness apps. The goal is to give users control over who sees their biometrics, how they are stored, and whether they can be sold. Dave outlines why this matters for anyone using Oura, Whoop, CGMs, or genetic testing and why your biology should belong to you and not the cloud. Source: https://natlawreview.com/article/federal-healthcare-update-november-7-2025 All source links provided for easy reference to the original reporting and research above. This is essential listening for fans of biohacking, hacking human performance, functional medicine, and longevity who want actionable tools from Host Dave Asprey and a guest who embodies what it means to age with energy, clarity, and vitality. Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights in health, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday (audio-only), and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: cocoa extract, flavanols, heart health, nitric oxide pathways, COSMOS trial, AI stethoscope, digital diagnostics, Keikku device, predictive health tech, beef organ supplements, women's hormonal health, nutrient dense foods, ancestral nutrition, spirulina benefits, collagen support, oxidative stress defense, green stacking, chlorella pairing, DNA protection, wearable privacy laws, HIPAA reform, biometric data rights, longevity news, biohacking updates Thank you to our sponsors! Essentia | Go to https://myessentia.com/dave and use code DAVE for $100 off The Dave Asprey Upgrade. ECHO Water | Go to http://echowater.com/dave and use code DAVE10 for 10% off your ECHO Flask. Resources: • Subscribe to my weekly newsletter: https://substack.daveasprey.com/welcome • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Upgrade Collective: https://www.ourupgradecollective.com • Upgrade Labs: https://upgradelabs.com • 40 Years of Zen: https://40yearsofzen.com Timestamps: 0:00 – Intro 0:19 – Cocoa Extract & Heart Health 1:52 – AI Digital Stethoscope 3:01 – Beef Organ Supplements 4:24 – Spirulina for Longevity 5:42 – Substack Announcement 6:53 – Health Data Privacy Reform 8:23 – Weekly Upgrade Protocol 9:46 – Outro See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

Continuous glucose monitors (CGMs) are small devices that are inserted just under the skin — usually on the back of the arm — to measure glucose levels. To date, they've been widely used by those with prediabetes or diabetes. However, they are now being embraced by a broader audience of health-minded individuals who are curious about the insights they can gather from them because of the far-reaching effects that glucose levels have on health.    This technology is becoming more accessible to the general consumer and in this episode, Cher Pastore, RD, joins us to speak about the options available, how they work and what they measure, and the ways the data can be used to improve health.   This episode of Life Time Talks is sponsored by Dexcom, the makers of Stelo.   Find the episode highlights, get related resources and view the transcript for this episode at https://experiencelife.lifetime.life/podcast/understanding-continuous-glucose-monitors-sponsored   Have thoughts you'd like to share or topic ideas for future episodes? Email us at lttalks@lt.life — we'd love to hear from you!   Follow us on Instagram: @lifetime.life   The information in this podcast is intended to provide broad understanding and knowledge of healthcare topics. This information is for educational purposes only and should not be considered complete and should not be used in place of advice from your physician or healthcare provider. We recommend you consult your physician or healthcare professional before beginning or altering your personal exercise, diet or supplementation program.

Blood sugar affects everything from your energy and sleep to your hormones and weight—yet most women are never taught how to manage it. In this episode, Kara Collier, RDN and co-founder of Nutrisense, shares what you need to know about CGMs, practical lifestyle hacks for glucose control, and the unique considerations women face after 35.Timestamps:[1:44] Intro[6:45] Interview with Kara[7:06] What did you see in your practice that made you realize blood sugar is a much bigger piece of the health puzzle?[10:51] Can you define what healthy blood sugar is, outside of markers on labs?[13:45] What does healthy blood sugar look like from a CGM perspective? [19:20] What's your opinion on why women are struggling more with blood sugar?[24:36] What do CGM's track and what data is most important? [36:10] Talk to me about the impact that stress has on our blood sugar and our ability to manage glucose.[41:06] What about exercise and sauna (the things that raise our heart rate)? What do we expect to see, what's normal, and what's not?[48:01] What are some of the most effective "hacks" in nutrition and exercise for blood sugar?[55:30] Do you think that carb timing influences blood sugar at all?[56:28] I got a CGM to see if there is anything obvious with my sleep.  Am I trying to avoid spikes all together? [1:03:04] How do we actually reverse insulin resistance? [1:09:56] Is fasting really good for blood sugar?[1:11:38] My 10 -year -old daughter has been wearing a CGM for about a month now. She has high anxiety and I noticed that when her anxiety is high, a juice box will calm her down at night. Once we put a CGM on her, we realize that her glucose is pretty low on average. How do we keep her glucose up without eating straight sugar all the time? What are some good glucose boosting snacks? Episode Links:Nutrisense CGMWell Minerals Vitamin CSponsors:Go to drinklmnt.com/wellfed and use code WELLFED to get a free 8-pack with any drink mix purchase!Go to curednutrition.com/wellfed and use code WELLFED for 20% off.Go to http://mdlogichealth.com/chocolate and use coupon code COLLAGEN15  for 15% off.Go to wellminerals.us/chill and use code WELLFED to get 10% off your order.

Sign up to Mondays Matter Xmas Edition https://www.mikkiwilliden.com/mondays-matterSave 20% on all Nuzest Products WORLDWIDE with the code MIKKIPEDIA at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comCurranz Supplement: Use code MIKKIPEDIA to get 20% off your first order - go to www.curranz.co.nz  or www.curranz.co.uk to order yours In this episode, I'm joined by exercise physiologist and nutrition researcher Dr Abby Smith-Ryan to unpack what really happens to women's metabolism through perimenopause and beyond. Abby explains why a sufficiency-based approach to women's health research matters, and why “the science is settled” is the wrong way to think about female physiology. We dig into metabolic changes in midlife, low energy availability, and why so many women are unintentionally under-fuelling while feeling “weight-loss resistant.” Abby shares her latest work on nutrient timing, fed vs fasted training, pre-exercise protein, and how progressive resistance training (with and without creatine) can rapidly improve muscle, fat mass, bone and confidence in midlife women. We also touch on GLP-1s, metabolic flexibility, CGMs, and daily urine hormone tracking as emerging tools for understanding this life stage.Episode highlightsWhy women's research needs a “sufficiency” rather than “scarcity” mindsetHow under-eating, stress and low energy availability drive metabolic slowdown in midlifeFed vs fasted training, pre-workout protein, and practical nutrient timing for womenNew data on resistance training, creatine, and rapid changes in muscle, fat and bone in perimenopauseUsing CGMs and daily urine hormone tracking to better understand symptoms and tailor training Contact Mikki:https://mikkiwilliden.com/https://www.facebook.com/mikkiwillidennutritionhttps://www.instagram.com/mikkiwilliden/https://linktr.ee/mikkiwilliden

So many women in midlife are doing everything right (eating clean, exercising, managing stress) yet still feeling off. The missing link? Blood sugar.In this episode of The Well Drop, I sit down with Boris Berjan to explore how continuous glucose monitoring (CGM) is changing the way women understand their metabolism, hormones, and energy.We talk about why most CGMs give you numbers without context, how Theia translates those readings into clear daily scores, and the hidden ways stress, sleep, and even emotional triggers can spike glucose just like food.You'll learn how to spot early signs of blood sugar imbalance, how syncing your fasting and nutrition with your cycle can help balance hormones, and why data only matters when it's personal and easy to act on.Boris Berjan is the co-founder of Theia Health, a company reimagining continuous glucose monitoring (CGM) for women. He also shares his own healing journey and how it inspired him to build tech that puts real insight and power back into women's hands.What's Discussed:(00:00) Why midlife symptoms aren't just hormonal and how glucose plays a hidden role(04:49) The real reason most CGMs fail women in midlife(08:55) A personal story that inspired a smarter health tech(18:26) How this app turns confusing glucose data into simple, actionable insights(25:41) The role of AI in making nutrition and tracking more personal and easier(35:10) How stress, sleep, and emotions can spike glucose like carbs(38:20) The future of CGM technology and what's coming next(42:42) Making health data personal and empoweringThank You to Our Sponsors:Theia Health: https://theiahealth.ai/Find out more about Amber Berger:Website: www.thewelldrop.comInstagram: @thewelldropFind out more about Boris Berjan:Instagram: @borisberjan/Theia Health: https://theiahealth.ai/

In this episode of Acquisitions Anonymous, the hosts dig into a $4.4 M e‑commerce business in the diabetes sensor accessory space and debate whether its 41% net margin, Australian base, and licensing opportunity make it a smart buy—or a risky startup in disguise.Business Listing – https://websiteproperties.com/websites/13755-sticking-with-success-great-business-opportunity-in-the-growing-diabetes-market/Welcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.

In this episode of Acquisitions Anonymous, the hosts dig into a $4.4 M e‑commerce business in the diabetes sensor accessory space and debate whether its 41% net margin, Australian base, and licensing opportunity make it a smart buy—or a risky startup in disguise.Business Listing – https://websiteproperties.com/websites/13755-sticking-with-success-great-business-opportunity-in-the-growing-diabetes-market/Welcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.

Your immune system isn't just about fighting infections—it's a mirror of your overall metabolic health.In this episode of A Whole New Level, Dr. Sharon Bergquist, physician and Director of Emory's Healthy Aging and Resilient Aging Center, joins Mike Haney to unpack the science of immune resilience—how chronic inflammation, white blood cell patterns, and metabolism intertwine to shape long-term health.Dr. Bergquist explains why inflammation isn't always bad, how the immune system ages, and what you can do daily to build resilience.They discuss:The link between metabolic dysfunction and chronic low-grade inflammationHow white blood cell counts reveal immune status and stress levelsWhy gut and liver health are central to immune balancePractical habits that calm inflammation and support immune recoveryWhat it really means to have a “resilient” immune systemSign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl

Thank you for tuning in for another episode of Life's Best Medicine. Dr. David Cavan is a leading diabetes specialist and author dedicated to helping people take control of their blood sugar and reverse type 2 diabetes through practical lifestyle changes. A former Director of Policy and Programmes at Diabetes UK, he has over 25 years of clinical experience and has advised globally on diabetes prevention and management. Dr. Cavan is the author of several influential books, including Reverse Your Diabetes and Take Control of Type 1 Diabetes, empowering patients with evidence-based, sustainable strategies for better health.   In this episode, Drs. Brian and David talk about… (00:00) Intro (04:07) Diabetes reversal (08:34) The history of managing diabetes with low carb diets (12:50) How Dr. Cavan discovered the power of diet for managing diabetes (22:52) Systemic issues in medicine related to nutritional advice and chronic disease (28:15) The growing acceptance of low carb diets as a therapy for diabetes (30:15) CGMs (31:05) Metabolic psychiatry (37:55) Type 1 Diabetes care (45:36) CGMs (49:56) Diabetes in Africa and lifestyle intervention (58:09) Outro   For more information, please see the links below. Thank you for listening!   Links:   Dr. David Cavan: The Diabetes Doctor: https://www.thediabetesdoctor.co.uk   Dr. Brian Lenzkes:  Arizona Metabolic Health: https://arizonametabolichealth.com/ Low Carb MD Podcast: https://www.lowcarbmd.com/ Brain Bootcamp: https://prescott-now.com/event/brain-bootcamp-resource-event/   HLTH Code: HLTH Code Promo Code: METHEALTH • • HLTH Code Website: https://gethlth.com

Marina Pavlovic Rivas, co-founder and CEO of Eli Health, reveals a revolution in personal health monitoring through advanced wearable devices. They discuss the journey from primitive step counters to sophisticated devices, such as continuous glucose monitors (CGMs) and the world's first instant hormone monitoring system by Eli Health. The conversation delves into the new cortisol testing kit from Eli Health, exploring its implications for understanding stress, sleep, metabolism, and overall health. Rivas explains the process of using the device, its integration with a smartphone, and how AI helps interpret the hormone data for actionable insights. Future plans for Eli Health's hormone monitoring technology, including progesterone and testosterone, are also discussed, offering a glimpse into the evolving landscape of self-monitoring and personalized health.

Taking a photo of your food and getting an accurate carb count seemed like a pipe dream just a few years ago, but this week's guest says it's here. Snaq wants to help you get nutritional info, and then see how that food actually affects blood glucose, thanks to integrations with CGMs, insulin pumps, and activity trackers. Snaq founder Aurelian Briner explains how his wife's type 1 diagnosis inspired the company, how it all works (and who owns the data), and what's next. Learn more about Snaq here Clinical Trial with Snaq here This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

Dietitians Aidan Muir and Torwen Eerkens discuss the utility of continuous glucose monitors (CGMs) for healthy individuals. They explore how CGMs work, the science of glucose metabolism, and the potential benefits and drawbacks of using these devices. The conversation highlights the importance of understanding individual responses to glucose levels and the implications of monitoring for both athletes and the general population.  (00:30) - Background on Continuous Glucose Monitors (01:23) - Glucose Metabolism (03:46) - Potential Benefits of Glucose Monitors for Healthy People (08:05) - Potential Downsides  (11:00) - Overall Thoughts & Recommendations WEBSITE:  https://www.idealnutrition.com.au/ PODCAST:  https://www.idealnutrition.com.au/podcast/ INSTAGRAM:  https://www.instagram.com/idealnutrition__/?hl=en Our dietitians

Feeling tired, craving sugar, or struggling to focus? You're not alone — 88% of Americans have poor metabolic health, and most don't even realize it. In this episode of Get Well Better by The Lanby, Registered Dietitian and Wellness Advisor Taylor Fazio breaks down why blood sugar balance is the foundation of health — and how small daily habits can create massive changes in your energy, hormones, sleep, and longevity.Learn what metabolic health really means, how continuous glucose monitors (CGMs) give you real-time insight into your body, and why stabilizing your blood sugar may be the most powerful thing you can do for your overall well-being.Taylor also shares practical tips you can start using today — like how the order of your meals can reduce glucose spikes by 70%, why a 10-minute walk after eating is pure magic, and how sleep and stress affect your metabolism as much as food.Plus, get a sneak peek at The Lanby's upcoming CGM Masterclass — a 4-week guided program designed to help you personalize your nutrition, movement, sleep, and stress using your own glucose data.Learn more or sign up for The Lanby CGM Masterclass: https://www.thelanby.com/metabolic-healthSubscribe to Get Well Better by The Lanby: Apple Podcasts: https://podcasts.apple.com/us/podcast/get-well-better Spotify: https://open.spotify.com/show/get-well-betterYouTube: @TheLanby Or search “Get Well Better by The Lanby” on your favorite podcast platform!VISIT THE LANBY: Explore membership and learn more about The Lanby's functional medicine approach:https://www.thelanby.comFOLLOW THE LANBY ON SOCIAL: Instagram: https://www.instagram.com/thelanby Tiktok: https://www.tiktok.com/@thelanby LinkedIn: https://www.linkedin.com/company/thelanbySTAY IN THE KNOW: Subscribe to The Lanby newsletter for health tips, podcast drops, and expert insights: https://www.thelanby.com/newsletter

Gene therapy isn't science fiction anymore, it's becoming one of the most exciting frontiers in diabetes care. In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman sit down with Dr. Fraser Wright, career gene therapist and Co-Founder/Chief Gene Therapy Officer at Kriya Therapeutics, to explore how gene therapy could one day help the body make its own insulin.Together, they unpack what gene therapy actually is, Dr. P's involvement as a medical consultant for Kriya Therapeutics, how AAV (adeno-associated virus) vectors work, and what makes this “one-and-done” approach so different from traditional treatments. From success stories in blindness and hemophilia to emerging type 1 diabetes studies, the trio breaks down the science, the safety, and the hope behind this revolutionary research.You'll learn how gene therapy has moved from rare diseases to more common ones, why the first human trials in diabetes are on the horizon, and what and what this could mean for long-term blood sugar control and independence from injections.Key Topics:Gene Therapy 101: How gene therapy differs from protein-based drugs like insulin, and why AAV vectors act as safe, engineered delivery vehicles rather than infectious viruses.Why AAV, Why Now: Seven FDA-approved AAV-based therapies have proven the potential of long-term, single-dose treatments.From Eyes to Endocrine: Lessons learned from retinal gene therapy are now guiding approaches to metabolic conditions like diabetes.The Type 1 Diabetes Approach: A muscle-targeted program aims to help the body naturally produce insulin and stabilize blood sugar levels.Control and Safety: Built-in glucose sensing and the ability to turn off gene expression ensure precision and reversibility.Real-World Considerations: How exercise, treatment site, and existing technologies like pumps or CGMs could work alongside this therapy.0:00 – Intro: Jeremy and Steve introduce gene therapy and why this topic is a game-changer2:15 – What gene therapy is and how it's different from standard protein-based treatments4:54 – Understanding AAV: safety, engineering, and why it's the preferred delivery method8:50 – Real-world success: seven FDA-approved AAV therapies for genetic diseases12:20 – Lessons learned from treating blindness and how they apply to diabetes17:40 – The Type 1 Diabetes model: using muscle tissue to produce insulin22:15 – Managing control, glucose sensing, and preventing hypoglycemia25:50 – Safety measures and how treatment can be reversed locally if needed28:30 – Exercise, durability, and what animal studies reveal about real-life performance31:10 – Timelines, trials, and what's next for gene therapy in diabetes. What's Ahead: Clinical trials expected to begin around 2026, offering cautious but real optimism for the future of diabetes treatment.Visit TCOYD's Website for more diabetes edutainment for people living with diabetes: tcoyd.org**Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!**Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook  |  Instagram  |  YouTube ★ Support this podcast ★

Save 20% on all Nuzest Products WORLDWIDE with the code MIKKIPEDIA at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comCurranz Supplement: Use code MIKKIPEDIA to get 20% off your first order - go to www.curranz.co.nz  or www.curranz.co.uk to order yours  In this episode, Mikki speaks with Professor Michael Snyder, Chair of Genetics at Stanford University and a global leader in personalised medicine. They explore how our genes, gut microbiome, and lifestyle choices interact to shape metabolic health—and why we all respond so differently to the same foods. Mike shares insights from his groundbreaking research using wearables and genomics to track health in real time, the future of personalised nutrition, and how continuous glucose monitors (CGMs) can help anyone understand their body better. They also discuss the link between viral infections and diabetes, why strength training matters more than you think, and how food truly functions as medicine.Highlights:The genetics of metabolic individuality and why “one-size-fits-all” diets don't workHow CGMs reveal surprising glucose spikes and help improve long-term healthThe microbiome's crucial role in metabolism and disease riskSubtypes of diabetes and what they mean for treatment and lifestyleWhy Professor Snyder believes health tracking is the future of preventive medicine Contact Mikki:https://mikkiwilliden.com/https://www.facebook.com/mikkiwillidennutritionhttps://www.instagram.com/mikkiwilliden/https://linktr.ee/mikkiwilliden

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, I sit down once again with returning guest and college athlete Jaci Carpenter for an honest conversation about the realities of navigating diabetes care as a young adult. From frustrating endocrinology visits and inflated medical costs to learning how to advocate for yourself and manage nutrition beyond “just taking insulin for what you eat,” this episode shines a light on what so many people with diabetes face every day.Our Deep Dive Includes:Why Jaci's recent endocrinology experience left her classified as a “high-risk diabetic” — and what that really meansHow the healthcare and insurance systems often fail those who are doing everything rightThe emotional and financial weight of affording insulin, CGMs, and pump suppliesLearning to question outdated medical advice and advocate for your own careThe difference between textbook diabetes management and real-life diabetes management as an athleteWhy nutrition is more than carb counting — and how to make food choices that support long-term health and stabilityFinding balance between discipline, mental health, and living your life freely with diabetes

If you want to improve your energy and long-term health, start by understanding how your body uses glucose.In this episode of A Whole New Level, Dr. Benjamin Bikman, scientist and author of Why We Get Sick, joins Mike Haney to unpack the science of glucose metabolism and insulin resistance—and why blood sugar isn't the whole story.Dr. Bikman explains how insulin regulates energy balance, why HbA1c is only part of the picture, and how chronic high insulin can silently drive weight gain, fatigue, and metabolic disease. He also shares practical ways to lower insulin naturally through diet, exercise, and daily habits.They discuss:Why insulin, not glucose, is the root of metabolic dysfunctionWhat HbA1c and fasting glucose really tell youThe early signs of insulin resistance most people missHow muscle tissue protects against high glucose and insulinWhy low-carb and intermittent fasting aren't one-size-fits-allPractical nutrition and movement strategies for better metabolic flexibilitySign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl

In this episode, host Lindsey Elizabeth Cortes, a sports dietitian and entrepreneur, delves into the world of female athlete nutrition with guest Nick Padula, a private practice sports dietitian and professor at the University of Southern California. They discuss the importance of personalized nutrition, the impact of dietary choices on performance, and the power of comprehensive testing, including continuous glucose monitors (CGMs), genomics, and microbiome analysis.   Nick shares his experiences working with various athletes, from boxers to endurance runners, and underscores how detailed nutrition data can significantly enhance training and recovery. Lindsey and Nick also explore practical approaches to fueling for both everyday athletes and elite sports performers, emphasizing the difference between generalized guidelines and individualized nutritional insights.   Episode Highlights: 01:24 Meet Nick Padula: Sports Dietician Extraordinaire 02:50 The Intersection of Clinical and Sports Nutrition 04:14 The Science and Ethics of Weight Cutting 09:52 Customizing Nutrition Through Testing 17:06 Understanding Genomic and Microbiome Testing 26:26 Addressing RED-S and Support Options 29:13 Understanding Gluten Intolerance 32:28 The Role of Continuous Glucose Monitors (CGMs) 35:37 Practical Applications of CGMs 42:05 The Importance of Recovery Nutrition 45:30 Exploring Nutrition Packages and Testing 47:07 The Impact of Environmental Toxins 53:31 Fun Questions and Final Thoughts Nick Padula has been a practicing Dietitian since 2015 as a clinical dietitian, a foodservice director. In addition to You Trition, LBC Nutrition, a dietetic consultant company, is a lecturer and coordinator with the University of Southern California Master’s in Nutrition program and Sports Dietitian for Cypress Junior College Athletics. ⁠   Nick studied nutrition and dietetics at Long Beach State University and received a Bachelor's degree in 2012 and Master's degree in Nutrition and Dietetics with a concentration in Sports Nutrition from Texas Tech University. ⁠In his practice he has worked with triathletes, professional boxers, endurance runners, professional soccer players, high school athletes, and the USC football and basketball teams. Nick is an avid runner, weightlifter, and golfer.   Connect with Nick: www.youtritionscience.com IG:@Youtrition_science Email: nick@youtritionscience.com   Resources and Links: For more information about the show, head to work with Lindsey on improving your nutrition, head to: http://www.lindseycortes.com/ Join REDS Recovery Membership: http://www.lindseycortes.com/reds WaveBye Supplements – Menstrual cycle support code LindseyCortes for 15% off: http://wavebye.co Previnex Supplements – Joint Health Plus, Muscle Health Plus, plant-based protein, probiotics, and more; code riseup for 15% off: previnex.com Female Athlete Nutrition Podcast Archive & Search Tool – Search by sport, condition, or topic: lindseycortes.com/podcast Female Athlete Nutrition Community – YouTube, Instagram @‌femaleathletenutrition, and private Facebook group

In this episode, Tina sits down with fellow FDN practitioner Michele Scarlet for an honest conversation about women's health, metabolism, and weight loss. Michele shares her personal story with breast implant illness and how the hidden toxic load on her body impacted her health. They discuss why “healthy habits” like 4 a.m. workouts, fasted training, and constant discipline and willpower can sometimes do more harm than good, and why the “calories in, calories out” approach fails without strong metabolic health. The conversation also dives into the real causes of bloating, the crucial role your liver plays in energy and fat loss, and how to naturally support it for better hormone balance. Michele helps clear up confusion around carbs, belly fat, and CGMs while offering practical strategies to help women achieve true, sustainable health. Here's what you'll learn: - Her personal story with breast implant illness and the hidden toxic load on her body - Why your 4 a.m. workouts, fasted training, and pushing harder could be stalling your progress - Why willpower and discipline aren't the answer and what you should do instead - Why calories in, calories out fails without strong metabolic health - What constant bloating really means and how to fix it - The overlooked role your liver plays in weight loss and metabolism - How to naturally support your liver for better energy and fat loss - Clearing up confusion around carbs, belly fat, and CGMs Explore microdosing and other peptides: https://elliemd.com/tinahaupert Peptides for Women: https://carrotsncake.com/offers/3Q7wttmr?coupon_code=PROTOCOL19 Connect with Tina Haupert: https://carrotsncake.com/ Facebook: Carrots 'N' Cake https://www.facebook.com/carrotsncake Instagram: @carrotsncake https://www.instagram.com/carrotsncake YouTube: Tina Haupert https://www.youtube.com/user/carrotsncake About Tina Haupert: Tina Haupert is the owner of Carrots ‘N' Cake as well as a Certified Nutrition Coach and Functional Diagnostic Nutrition Practitioner (FDN-P). Tina and her team use functional testing and a personalized approach to nutrition to help women find balance within their diets while achieving their body composition goals. Connect with Michele Scarlet: https://www.michelescarlet.com/ IG: https://www.instagram.com/michelescarlet_ Youtube: https://www.youtube.com/@michelescarlet_/videos About Michele Scarlet: I've spent over 15 years helping women feel strong, confident, and in control of their health. But it wasn't until I faced my own struggles with fatigue, hormone imbalances, and weight loss resistance that I realized true health goes far deeper than diet and exercise. That's when I turned to functional lab testing and a whole-body approach—and it changed everything. Now, I help women uncover the root cause behind their low energy, hormonal imbalance and their weight loss struggles to achieve lasting results, all while reclaiming the motivation and vitailty they thought they'd lost forever. As a Board-Certified Functional Medicine Practitioner, Functional Diagnostic Nutrition Practitioner, Certified Personal Trainer, and Women's Health Coach, I bring science, strategy, and compassion to every woman I work with.

Alzheimer's and dementia aren't just a matter of age or genetics. Increasing evidence shows that metabolic health—particularly insulin resistance—plays a key role in cognitive decline.In this episode of A Whole New Level, neurologist and bestselling author Dr. David Perlmutter joins Mike Haney to explore the links between brain health and metabolism. They discuss the role of insulin resistance and inflammation in Alzheimer's disease, the biomarkers that can reveal risk decades before symptoms, and how lifestyle interventions can dramatically change your trajectory.Topics include:Key biomarkers for assessing brain health: fasting insulin, A1C, homocysteineWhy targeting inflammation may matter more than targeting amyloid plaquesThe promise and limitations of GLP-1 medications for dementia and Parkinson'sPractical steps you can take now to protect long-term cognitive functionSign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl

In this episode of The Lisa Fischer Said Podcast, Lisa sits down with Kara Collier, registered dietitian and co-founder of Nutrisense, to unpack the truth about metabolic health, insulin resistance, and how continuous glucose monitors (CGMs) are transforming the way we understand our bodies. Kara shares why she left traditional healthcare, the shocking flaws in hospital nutrition, and how real-time data from CGMs empowers behavior change. Whether you're keto, carnivore, plant-based, or just curious, this episode reveals why everyone should wear a CGM at least once. Learn how glucose, insulin, fasting, aging, and hormones all play into the metabolic puzzle—and how Nutrisense is helping thousands take control of their health.     WEBSITE: https://www.karacollier.com/courses/GlucoseAcademy     Nutrisense Page with 33% Discount: https://www.nutrisense.io/marketing/kara-collier     INSTAGRAM: https://www.instagram.com/karacollierrd/     INSTAGRAM:  https://www.instagram.com/nutrisenseio/     FACEBOOK: https://www.facebook.com/nutrisenseio     EPISODE SPONSOR:  https://www.davidsburgers.com/     EPISODE SPONSOR:  https://marlsgate.com     LISA'S LINKS:     Lisa Fischer Said Academy:  https://lisafischersaid.com/academy/     Website:  lisafischersaid.com     For more information on group intermittent fasting  coaching with Lisa, email fasting@lisafischersaid.com     For more information on one-on-one or group health coaching with Lisa, email healthcoaching@lisafischersaid.com     Podcast produced by clantoncreative.com    

In this episode of the HealthspanMD Podcast, Dr. Robert Todd Hurst, MD, FACC, FASE sits down with Patty and Rick Rife to unpack their powerful journey through proactive, personalized care. After years of strict vegan eating, they were shocked to discover early signs of heart disease, prediabetes, and rising blood pressure. What followed was a complete transformation driven by advanced testing, continuous glucose monitoring, and a tailored plan that actually worked for their bodies.   In this episode of the HealthspanMD Podcast, Dr. Robert Todd Hurst, MD, FACC, FASE sits down with Patty and Rick Rife to unpack their powerful journey through proactive, personalized care. After years of strict vegan eating, they were shocked to discover early signs of heart disease, prediabetes, and rising blood pressure. What followed was a complete transformation driven by advanced testing, continuous glucose monitoring, and a tailored plan that actually worked for their bodies.   They share how switching to a low-carb, high-protein diet led to dramatic improvements in energy, labs, and overall health, and why health is always a team effort. Whether you're feeling stuck with your current plan or wondering if your numbers tell the whole story, this episode is a must-listen.   Patty and Rick Rife are a health-conscious couple who came to HealthspanMD looking for clarity, not just checkups. After four years on a strict plant-based diet, Rick's elevated calcium score, insulin resistance, and surprising lab results sparked a major shift. Under the guidance of Dr. Robert Todd Hurst, MD, FACC, FASE, they adopted a more personalized, results-driven approach and reversed their risk trajectory in weeks.    Key Timestamps 00:00 – Meet Patty and Rick Rife + why they came to HealthspanMD 02:00 – Going vegan for heart health: expectations vs reality 04:30 – Early signs of arterial plaque and metabolic dysfunction 06:00 – When “healthy” isn't enough: lab results that shocked them 08:15 – From vegan to low-carb: making the dietary pivot 11:00 – Dramatic changes in A1C, triglycerides, and insulin in 5 weeks 13:45 – The power of CGMs for personalized feedback 15:30 – “Healthy” foods that spiked blood sugar, and what didn't 18:30 – How food order, stress, and walking affect glucose response 21:00 – Why one diet does not fit all 24:00 – Repatha, medication strategy, and reversing artery disease 27:00 – Mindset shifts, confidence, and redefining health together 30:00 – Health as a team sport and what's next for the Rifes This information is for educational purposes only and is not medical advice. Don't make any decisions about your medical treatment without first talking to your doctor. *Connect* *with* *HealthspanMD* :

Send us a textHarvard-trained physician-scientist Dr. Nick Norwitz joins me to unpack the real drivers of metabolic health. He shares how keto sent his severe ulcerative colitis into remission within one week, why “calories in, calories out” is a dead-end tautology, what happened when he overfed ~6,000 calories/day and didn't gain weight, and how medical training ignores nutrition while Big Food-friendly myths persist. We hit CGMs in med-ed, GLP-1s, statins' surprising effects on GLP-1, funding unbiased metabolic research, and whether long-term keto is not just therapeutic but optimal.Where To Find Nick Norwitz:Youtube:  @nicknorwitzMDPhD  Website: https://www.nicknorwitz.com/Instagram: https://www.instagram.com/nicknorwitz/X: https://x.com/nicknorwitz

Type 2 diabetes is one of the most common chronic conditions in the U.S., but it doesn't have to define or limit your life. In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus—two endocrinologists with decades of experience—break down practical strategies for living well with type 2. From the latest medications and tools to everyday lifestyle choices, they highlight what really makes a difference in the long run. Their goal? To show you that type 2 diabetes is not only manageable but that taking control can actually improve your health and quality of life.Get Educated About What's Happening in Your Body: Understanding insulin resistance, metabolic syndrome, and why type 2 diabetes is more than just “high blood sugar.”Know Your Numbers: The key benchmarks for A1c, blood sugar, cholesterol, and blood pressure—and why even small improvements matter.Build the Right Care Team: How to find and work with providers who can guide you through treatment options and keep you on track.Food and Drink That Work for You: Why portion control, balance, and smart substitutions matter more than strict diets or deprivation.Move Your Body (Without Overthinking Exercise): How realistic activity goals—walking, stretching, or even gardening—can improve insulin sensitivity and overall health.The Medications Changing the Game: Why GLP-1s, SGLT2 inhibitors, and CGMs are considered life-changing tools in type 2 diabetes care—and what you should know about them.And That's Just the Start…: From mental health to long-term complication prevention, there are even more strategies in this episode to help you thrive with type 2 diabetes. ★ Support this podcast ★

Longevity is a hot health topic, but what factors move the needle on not only how long you live but how long you experience relatively good health? Some lab and other tests can help assess how healthy you're aging and provide context for what lifestyle and other changes to make. Dr. Matt Kaeberlein and Mike Haney discuss the tests that help assess healthy aging, how mental health and physical health are intricately connected, which lifestyle factors might expand your health span, and where the research stands on various longevity topics.Get a Free Guide to Understanding Your Lab Results: https://levels.link/wnl

Text us a comment or question!Ever wonder why some foods leave you energized and satisfied while others knock you into a mid-afternoon crash - or make fat loss feel impossible? The answer lies in your blood sugar. And today, we're breaking down how you can finally take control of it. In this episode, I sit down with Kara Collier, co-founder and VP of Health at Nutrisense, to uncover how continuous glucose monitoring (CGMs) and smart lifestyle strategies can help you outsmart stubborn fat, reclaim your energy, and build the lean, strong body you deserve in your 50s, 60s, and beyond. Kara is a Registered Dietitian and one of the leading voices in metabolic health. She's helped over 150,000 people use real-time data and practical tools to create sustainable change - and today, she's sharing those insights with you. What you'll learn in this episode:Why blood sugar spikes and crashes sabotage fat loss, energy, and cravingsThe surprising individuality of how foods affect your glucose (bananas might not be the villain after all!)Simple hacks to keep blood sugar balanced - without giving up your favorite foodsHow stress, sleep, and even the time of day can dramatically impact your glucose responseWhy building muscle is one of the most powerful tools for metabolic healthSupplements and “biohacks” that actually move the needle (and which ones are just pebbles, not boulders) Whether you're struggling with stubborn belly fat, daily energy crashes, or just want to feel younger and more vibrant, this conversation will show you how to finally master The Glucose Game. 

Hypoglycemia (low blood sugar) can be more dangerous than hyperglycemia (high blood sugar), especially because it can lead to immediate and life-threatening situations. While high sugar levels over time can damage organs and increase the risk of complications, a sudden drop in glucose can impair brain function, cause unconsciousness, seizures, stroke and even be fatal if not treated promptly. This is where Continuous Glucose Monitoring (CGM) systems have become a game-changer. Although traditional glucometers are still widely used, especially by individuals who take insulin three to four times a day, CGMs offer a more convenient and accurate option. Many people on insulin therapy are advised to check their blood sugar at least three times daily — which isn't always easy. CGMs solve this by offering real-time tracking and alerts via your smartphone. Worn on the arm or abdomen, CGMs can be programmed to alert you when your glucose levels begin to drop. For instance, if you set an alert at 90 mg/dL, the device might warn you at 88 mg/dL, giving you enough time to take action. This is especially beneficial for those with hypoglycemia unawareness, where symptoms are no longer felt even at dangerously low levels. It is also important to know that if someone has one episode of hypoglycemia, his risk of developing 2nd episode of hypo is higher and during this 2nd / 3rd hypo, the threshold for symptoms of recognition may go further low, this is known as Hypoglycemia-Associated Autonomic Failure (HAAF), can worsen with repeated episodes. Thus, we should avoid recurrent hypoglycemia episodes. To stay safe, especially for those new to diabetes care, never go more than 3.5 to 4 hours without eating. Even if you're not hungry, regular small meals are essential. Prioritize your health — and don't hesitate to communicate your needs at work or school. Expert - Dr. Sunil Gupta Anchor – Ms. Kalyani Gokhale Recorded on: 28/03/2025 Recorded at: Akashwani Nagpur

Amelia Wood is an ACE-certified Personal Trainer dedicated to helping people feel strong, confident, and capable in their own bodies. Known for her approachable, no-gimmicks style, Amelia focuses on building sustainable fitness habits that fit real life. She's passionate about functional strength, movement that feels good, and empowering others to discover just how resilient they can be. In this episode, Dr. Brian, Dr. Tro, and Amelia talk about… (00:00) Intro (04:04) Why Amelia started her podcast, The Magic of Metabolic Health, and became a personal trainer (13:42) Learning delayed gratification and sustainably healthy living (18:06) Learning to enjoy exercise (25:04) Looking for the ‘why' behind behaviors you want to change (30:56) The five stages of achieving success (35:18) Cultural considerations when building a sustainably healthy lifestyle (47:39) Merging acting, entertainment, and wellness (51:24) What it means to be a ‘food first' personal trainer (and why CGMs are awesome!) (01:06:53) Gut health and overall metabolic health (01:11:50) A1C, fat, and butyrate (01:18:32) Outro For more information, please see the links below. Thank you for listening!   Links:   Please consider supporting us on Patreon: https://www.lowcarbmd.com/   Resources Mentioned in this Episode: Food Addiction Reset: https://www.foodaddictionreset.com Nutrition Network: https://nutrition-network.org Tro on Amelia's Podcast: https://www.youtube.com/watch?v=hQQkpHmwIdE   Amelia Wood: IG: https://www.instagram.com/primitivepulsefitness/ Website: https://www.primitivepulsefitness.com Podcast: https://www.youtube.com/@themagicofmetabolichealth The Great Surprisal: https://www.instagram.com/thegreatsurprisal/?hl=en   Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author   Dr. Tro Kalayjian:  Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro IG: https://www.instagram.com/doctortro/   Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.    Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/ 

This week on We Are T1D, Mike and Jack tackle the ins and outs of Continuous Glucose Monitors (CGMs) — those little gadgets that keep an eye on your sugars around the clock, often with a bit of drama thrown in for good measure. From the beeping alerts that can wake you at 3 AM to the occasional sensor mishap, they explore how these devices can be both lifesavers and sources of anxiety.Join the duo as they delve into the specifics of CGMs, including their functionality, the different types available in the UK, and why trend arrows are a game changer. They share personal anecdotes, laugh at the chaos that comes with using CGMs, and even take a peek at some hilarious Reddit stories about sensor mishaps.What to Expect:The basics of how CGMs work and why they're essential for Type 1 diabeticsThe difference between the Dexcom and Libre systemsReal-life tales of sensor struggles and triumphsTips for keeping your CGM stuck on, even through showersFuture tech: What could CGMs look like in the coming years?“Without CGMs, diabetes would be 100 times harder.” – MikeConnect with Us:Email: wearet1dpodcast@gmail.comWebsite: www.wearet1d.comInstagram: @t1d_mike & @t1d_jackWhatsApp Community: Join hereExtra Resource:Diabetes UK – Continuous Glucose MonitoringHashtags:#Type1Diabetes #T1DLife #DiabetesPodcast #WeAreT1D #T1DCommunity #CGM #DiabetesTech

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, I sit down with Jenna Smith, who was diagnosed with Type 1 Diabetes at the age of 26. Jenna shares her powerful story of living with T1D for nearly two decades, navigating the challenges of motherhood, divorce, intimacy, and dating, while also facing a breast cancer diagnosis in 2023.Jenna's openness about the emotional and physical toll of managing both T1D and cancer highlights the importance of resilience, community, and giving ourselves grace. From her early resistance to diabetes technology, to finding the courage to embrace diabetes tools Jenna's perspective offers hope and relatability for anyone living with this condition.This conversation dives into the real, messy, and inspiring realities of diabetes management—and the strength it takes to keep moving forward.

Today I'm sitting down with Dr. Filip Larsen, the physiologist behind a tiny green shot that pros say helps them go harder with less burn. One preprint shows lower blood lactate at the same power after a single dose; WorldTour riders like Mads Pedersen claim they feel a real boost. But is it biology or placebo? We'll unpack the science, design a blinded test I can do on the bike, and then go way beyond the drink: overtraining, CGMs, mitochondria, and how to actually train smarter. NOMIO is clinically proven to:Lower lactate levels, Reduce oxidative stress, Improve training adaptations And deliver a noticeable boost from the very first dose. Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.drinknomio.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and check out this game changing supplement. 4iiiiReady to elevate your cycling game? Trust the 4iiii PRECISION 3+ Powermeter—precision, performance, and peace of mind, all in one.Learn more by visiting http://www.4iiii.comSHOPIFY Turn your big business idea into reality with Shopify on your side. Sign up for your one-dollar-per-month trial and start selling today at www.shopify.co.ukLlyods By partnering with British Cycling, Lloyds is helping more people experience the joyof riding and showing how those small personal pedal strokes can move us all forward.So if you haven't already, maybe now is the time to get on a bike yourself. Lloyds, thereat every stage.EXPOSURE LIGHTS Level up your night rides—check out the updated Exposure Lights bar range today at www.exposurelights.com If you're in North America and run a shop, pre-orders are open now; everyone else, hit your local bike store or Exposure online and tell them Roadman sent you.LLYODSBy partnering with British Cycling, Lloyds is helping more people experience the joy of riding, and showing how those small personal pedal strokes can move us all forward.

Living with type 1 diabetes is a daily grind, full of numbers, decisions, and constant adjustments, but it doesn't have to feel overwhelming. In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus two endocrinologists who also live with T1D, share their top 10 tips for making life with diabetes more manageable and a little easier to navigate. They cover everything from setting realistic blood sugar goals and understanding the metrics that matter most, to smart supply hacks that can save you stress when you least expect it. They also dive into why celebrating the small wins like getting through the night without a low or nailing your pre-meal insulin timing can make a big difference in your long-term mindset. Whether you're newly diagnosed or decades into the journey, this episode is packed with advice you can use today and into the future.Key Topics:Perfection Isn't the Goal: Why aiming for progress—and not flawless numbers—keeps you healthier and less stressed.Know the Benchmarks That Matter: A1C, time in range, and minimizing hypoglycemia are key to long-term health.Celebrate the Small Wins: Even the little victories count, and they help build momentum in the day-to-day grind.Be Prepared With Backups: Why extra insulin, CGMs, and supplies are non-negotiable.Don't Forget the “Non-Blood Sugar Stuff”: Eye exams, blood pressure, and cholesterol deserve just as much attention.And There's More… From food strategies to mental health hacks, this episode is packed with practical advice you won't want to miss—tune in for all 10 tips!Visit TCOYD's Website for more diabetes edutainment for people living with diabetes: tcoyd.org**Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!**Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook  |  Instagram  |  YouTube ★ Support this podcast ★

Your thyroid test results explained: The thyroid is a butterfly-shaped gland in your neck that affects many facets of health. When it doesn't function optimally, symptoms can ensue. That's where testing comes in, but the results can be tricky to interpret (and treat if necessary) without a knowledgeable clinician. Dr. Angela Mazza and Mike Haney discuss thyroid function, thyroid hormone and related tests and what they mean, treatment for thyroid conditions, the benefits of an integrative approach to thyroid care, and more.Get a Free Guide to Understanding Your Lab Results: https://levels.link/wnl

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this inspiring episode, I sit down with twin sisters Lisa and Lindsay Rusch, both living with type 1 diabetes, alongside their older brother who also has T1D. Beyond their personal diabetes journeys, the sisters are co-owners of Brekkie Shack, a health-focused restaurant in Columbus, Ohio. This episode is packed with wisdom, entrepreneurial spirit, and practical tips for anyone managing diabetes—or supporting someone who is.

Hi friends! I have a brand new episode live, and today I'm diving into a powerful conversation with Kara from NutriSense all about metabolic health, continuous glucose monitoring, and the role of human connection in building sustainable lifestyle changes. I'm SO excited for you to listen to it!! Here's what we chat about: Why metabolic health is the foundation for your energy, focus, and long-term wellness The most common dietary mistakes that spike blood sugar (and how to avoid them) How continuous glucose monitors (CGMs) can give you real-time insights into your body The importance of stress management and its impact on blood sugar regulation Why AI can support—but never replace—the empathy of human coaching Practical strategies for creating small, sustainable healthy habits that actually stick This episode is packed with insight and encouragement to help you take control of your metabolic health and feel your best every day. Kara Collier is the co-founder and VP of Health at Nutrisense, one of the fastest-growing health tech startups in the U.S. She's reshaping how we approach prevention, behavior change, and metabolic health. A Registered Dietitian Nutritionist and Certified Nutrition Support Clinician, Kara has helped over 150,000 people improve their health by combining real-time data, like continuous glucose monitoring, with personalized coaching and practical lifestyle strategies. She's a passionate advocate for how technology and human support can drive sustainable health change. Kara is a Forbes 30 Under 30 honoree and has been recognized with HLTH's "Food as Medicine" award. Her work has been featured by Forbes, UC Berkeley, and Medcitynews and she is a frequent speaker at health conferences and podcasts. When she's not talking about health and data, Kara is usually exploring the mountains, playing volleyball, or lifting heavy things. Make sure you're subscribed to my newsletter For my free Autoimmune Healing ebook, click here. Detailed show notes here: https://fitnessista.com/podcast Partners: Check out We Feed Raw! Maisey goes crazy for this! I use it as a topper for her kibble or mix it into her pup loaf. You can try the raw version, the raw dehydrated kibble, and they'll help you customize a plan for your pup. Use FITNESSISTA40 for 40% off your Meal Plan Starter Box here!  Check out my new favorite red light device here, and use the code FITNESSISTA for a huge discount.  I've been using Nutrisense on and off for a couple of years now. I love being able to see how my blood sugar responds to my diet and habits, and run experiments. You can try out Nutrisense here and use GINA30 for 30% off.  If any of my fellow health professional friends are looking for another way to help their clients, I highly recommend IHP. You can also use this information to heal yourself and then go one to heal others, which I think is a beautiful mission. You can absolutely join if you don't currently work in the health or fitness industry; many IHPs don't begin on this path. They're friends who are passionate to learn more about health and wellness, and want to share this information with those they love. You can do this as a passion, or start an entirely new career. You can use my referral link here and the code FITNESSISTA for up to $250 off the Integrative Health Practitioner program. I highly recommend it!   Thank you so much for listening and for all of your support with the podcast! Please be sure to subscribe, and leave a rating or review if you enjoyed this episode. If you leave a rating, head to this page and you'll get a little “thank you” gift from me to you. http://fitnessista.com/podcastreview

His personal journey started as a retail pharmacist just trying to help diabetic patients. What he learned over the last decade is that teaching patients about the impact of diet, medications and lifestyle is the most valuable tool for improving health outcomes.He wanted to use his background as a pharmacist to fill that need for patient education. Unlike pharmacy school, he now has evidence-based information at his fingertips. And for the curious-minded, there are several clever ways to discover where conflicts of interest in the government, food, and pharmaceutical industries have shaped our misunderstanding of chronic disease. ​On a personal level, he found the ketogenic diet to be a powerful tool in helping him drop over fifty pounds and fuel his newly found passion for the watersport, SUP (stand-up paddle). He was able to achieve this goal and significantly improve various health markers. This personal dietary experiment added passion to his career transition from a traditional retail pharmacist to an educator and coach. Before he knew it, he was offering diabetes classes and leading a weekly support group. ​With recent advances in wearable technologies like CGMs (continuous glucose monitoring) and smart watches, patients can get important feedback in real-time regarding the consequences of their choices. His role is to facilitate learning as they navigate their own personal trek back to better health. https://www.unscriptedpharmacist.com/http://www.yourlotandparcel.org

Greater accessibility to glucose biosensors has led to their use to improve metabolic health, prevent disease, and feel better. Historically, these biosensors for monitoring glucose were only available with a prescription, often reserved for people with diabetes, but now with brands like Stelo, they are available over the counter. Dom D'Agostino, PhD, and Ben Grynol discuss how biosensors can be a tool for anyone to improve overall health, reduce risk for chronic diseases, manage women's health including menstrual cycles and the menopause transition, help with fueling strategies for workouts and performance, prevent energy crashes, and more.Sign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl

This is a story of faith, community, healing, and self-advocacy. Twenty years ago Amy Faith Folger discovered the keto diet. After reading Jason Fung's book on intermittent fasting she lost 85 pounds in 3 MONTHS! Thanks to her community, her faith, and her relentless pursuit of weight-loss strategies that work, she has been able, so far, to drop 160 pounds.   In this episode, Dr. Brian, Dr. Tro, Amy, and Adele talk about… (00:00) Intro (08:47) Losing weight on carnivore with lipodemiao (15:08) What NOT to do if you are a doctor trying to help a patient with lipodemiao and obesity (24:30) CGMs and stress (26:47) Taking care of yourself for the sake of the people in your life (35:05) Atrial fibrillation, obesity, and electrolyte deficiency (42:53) Insufficient education of patients on nutrition and the addiction component of  (45:00) Covid mRNA vaccine injury and death (51:39) The power of community and taking care of your gut biome (56:54) Why we need to teach people HOW to cook keto/carnivore meals (58:34) GLP-1s pros and cons (01:07:00) Outro   For more information, please see the links below. Thank you for listening!   Links:   Please consider supporting us on Patreon: https://www.lowcarbmd.com/   Resources Mentioned in this Episode: Paul Thacker on the LCMD Podcast: https://lowcarbmd.com/podcast/episode-280-paul-thacker-and-kris-newby/ Jason Fung's fasting book: https://www.amazon.com/Complete-Guide-Fasting-Intermittent-Alternate-Day/dp/1628600012   Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author   Dr. Tro Kalayjian:  Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro Instagram: https://www.instagram.com/doctortro/   Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.    Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/ 

IQBAR is offering our special podcast listeners 20% OFF all IQBAR products, plus get FREE shipping. To get your 20% off, text VANESSA to 64000. That's VANESSA to sixty-four thousand. Message and data rates may apply. See terms for details. Today's episode is a deep-dive recap of my mind-blowing conversation with Dr. Paul Laursen — one of the world's top experts in exercise physiology, high-intensity interval training (HIIT), and fat-adapted performance. If you've ever wondered: Why you feel better fat-fueled than carb-loaded How diet actually drives fat loss more than training Why ketones might be more than a fuel — and actually a proxy for VO₂ max How to optimize your metabolic flexibility using HIIT and protein-forward nutrition …this episode will change how you see your body composition journey — especially if you've been trying to out-exercise a poor diet.

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

 This episode is brought to you by Audible, LMNT and Cured Nutrition. In this episode of Ever Forward Radio, we sit down with Ben Azadi, author of Metabolic Freedom, to uncover the truth about metabolism and its role in energy, fat loss, and longevity. Ben shares why 93% of Americans are metabolically unhealthy, the dangers of the “glucose rollercoaster,” and why snacking may be accelerating aging. You'll learn the importance of fasting insulin testing, how muscle mass protects metabolic health, the role of stress and cortisol in stubborn fat, and simple strategies to move from metabolic “prison” to metabolic freedom. Follow Ben @thebenazadi Follow Chase @chase_chewning ----- In this episode we discuss... 00:00 – Introduction to Ben Azadi & Metabolic Freedom 03:02 – The “Glucose Rollercoaster” explained & why it matters 05:26 – Carb limits for prediabetes vs type 2 diabetes 08:41 – Fasting insulin: the real metabolic marker 10:26 – Affordable ways to improve metabolic health 11:39 – Snacking & the Hayflick limit: why grazing ages you faster 17:39 – The body's resilience vs the dangers of ignoring symptoms 19:14 – Metabolism myths: efficiency over speed 25:32 – How muscle mass prevents metabolic decline with age 29:17 – Post-meal walks & controlling insulin spikes 31:31 – Are glucose spikes really bad? The role of metabolic flexibility 33:35 – CGMs: useful tool or unnecessary gadget? 35:57 – Foundations first: food quality, sleep, stress, movement 37:48 – Stress, cortisol belly, and HRV tracking 41:18 – Cold plunging: benefits, risks, and adaptation 42:45 – Writing Metabolic Freedom: calories vs hormones & inflammation 45:48 – The power of belief: the refrigerator cart story 48:37 – What “Ever Forward” means to Ben Azadi 50:03 – Where to find Metabolic Freedom and connect with Ben ----- Episode resources: Free 30-day trial of Audible FREE variety sample pack with any purchase of LMNT 20% off Serenity Gummies with code EVERFORWARD Watch and subscribe on YouTube Learn more at BenAzadi.com

Can AI spot your health problems faster than a doctor? We all know the grind: long hours, too much stress, and that feeling of burnout that never seems to go away. Traditional medicine often just slaps a Band-Aid on the symptoms, leaving the root cause unaddressed. But what if there's a better way to get to the bottom of what's really going on with your body? Discover how AI-powered health tracking can pinpoint hidden issues like low testosterone and stress-induced glucose crashes. Learn how to use your own biometric data to have more productive conversations with your doctor. And find out what simple lifestyle changes can make a massive difference in your mental and physical well-being. Listen now to learn how to turn your health data into actionable insights. Topics Discussed: - AI and Testosterone: Garrett shares his personal journey of using an AI chat to pinpoint a potential diagnosis of hypogonadism due to head injuries, which was later confirmed by blood tests. - The Problem with Doctors: A major frustration is the lack of time doctors have to truly sift through a patient's complex history to find the root cause of issues like chronic stress or low energy. - Biohacking with Wearables: Wearable tech and continuous glucose monitors (CGMs) can reveal surprising correlations between emotional stress and physical biomarkers, like a fight with a partner causing a blood sugar spike. - The Biopsychosocial Model: The conversation highlights how physical health and mental health are inextricably linked and that physical issues can often manifest as psychological symptoms and vice versa. - Trusting Your Data: The hosts discuss the balance between trusting the data from wearables and listening to your own body's intuition, noting that the data isn't foolproof. - Quick Fixes vs. Root Causes: The discussion touches on how Western medicine often focuses on treating symptoms with quick fixes like medication, rather than addressing the underlying lifestyle factors. - The Power of Feedback Loops: Using AI and wearables creates a tighter feedback loop, allowing people to experiment with lifestyle changes and see the results faster, which helps maintain motivation. - Burnout as a Lifestyle Choice: Burnout is framed not just as a workplace issue but as a lifestyle problem driven by priorities that don't include recovery. - Behavioral Change is Hard: The hosts acknowledge that knowing what to do isn't the same as doing it, and that current behaviors often serve a purpose, even if they're unhealthy. - Data Privacy Concerns: Garrett acknowledges the risk of sharing personal health data with AI but weighs the benefit of gaining health insights against the potential for data leaks. Guest Website Gnosis Therapy (Garrett Wood's practice)  Garrett on LinkedIn Resource List: Home Readiness Assessment Books: The Biological Mind by Dr. Alan Jeffers  Wearable Tech: Oura Ring Continuous Glucose Monitors (CGM) 

Our kidneys filter out waste while retaining substances the body needs, such as electrolytes. Kidney health, which can be assessed with blood and urine biomarker tests, is paramount to overall health. Yet lifestyle, such as the Western diet and other factors, can damage the kidneys, leading to either a slow progression of issues or acute injury. Dr. Rick Johnson and Mike Haney discuss the role of the kidneys, what lifestyle factors affect kidney health, ways to support the kidneys, and what your biomarker results tell you about the function of these crucial organs.Sign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl

Episode #217 In this episode, Terri and Heather dive into the foundational framework behind lasting fasting success—what they call “The Three-Legged Stool.” They unpack the three essential components: 1️⃣ The Fasting Dial – finding the right rhythm for your body 2️⃣ The Nutrition Dial – nourishing in a way that supports your goals 3️⃣ The Support Dial – staying consistent through accountability and connection Terri and Heather explain why all three dials must be in balance—because when one leg is missing, the whole stool wobbles. If you're struggling to stick with fasting, lose weight, or feel your best, this conversation will help you reconnect with the core principles that create sustainable, long-term success. ✨ Think of this as your reset to realign and thrive—no extremes, just solid strategy.